Tim Sirichoke

Tim Sirichoke is the Chief Technical Operations Officer, responsible for all aspects of Technical Development, Manufacturing, and Quality.

Prior to joining, Tim was Vice President, INeST (individualized Neo-Antigen Specific Therapies) Manufacturing at Genentech. Vice President, Manufacturing at Kite Pharma, and at Novartis, head of Quality at the first cell and gene therapy site supporting the commercial production of Kymriah. Tim has a BS in Biology from the University of California at Berkeley.